Health Sciences

Cat Trail believes that the 21st century will experience tremendous advances in understanding mechanisms of action, and how to better manage disease, fueled by tireless scientific innovation and a growing aging population. These factors have created ever increasing and active investment opportunities within the Health Sciences sector. Between the years 2000 and 2025, the percentage of the U.S. population over 65 (as predicted by US Census) is projected to increase by 50%. This demographic trend and the resulting demand for healthcare goods and services will drive continued growth. Health care today accounts for over 15% of the U.S. Gross Domestic Product, up from under 6% in 1965. Today, advances in molecular medicine, genomics, and personalized therapy regimens have fueled novel research that continue to transform health sciences. Cat Trail hopes to help fund those pursuing innovative therapeutics based on molecular diagnostics, genetics, and evidence-based medicine which have the real potential to provide improved quality of life. Within the next decade, the health sciences industry including Biotech, Pharma, Diagnostics and Medical Devices are likely to make important progress in treating a plethora of disorders. Cat Trail partners with and supports select companies actively engaged in the pursuit of health related innovations. The following companies represent our current and past portfolio holdings.